Former Qualcomm Executive to Direct Corporate Strategy at Tandem Diabetes

Tandem Diabetes Care Inc., a leading insulin delivery and diabetes technology company, has appointed Elizabeth Gasser as its new executive vice president, Strategy and Corporate Development. Gasser will lead all activities related to evolving and implementing the Company’s long-term strategic direction in alignment with its mission to improve the lives of people with diabetes.
 
“Liz has been an instrumental consultant in recent months, providing insights to help shape and define our longer-term strategic business plan, which positions us to lead in insulin therapy management by building a robust ecosystem and portfolio of data-driven products and services,” said John Sheridan, president and CEO of Tandem Diabetes Care. “We are confident in her ability to lead in the implementation of these strategies as part of the executive management team and help drive Tandem’s continued success.”

Before becoming an independent advisor in 2017, Gasser led the corporate strategy function at Qualcomm Incorporated, working with the executive team and general managers of its various lines of business. During her 11 years at Qualcomm, she also led strategy and corporate development for its emerging business portfolio and the Qualcomm Internet Services division. Prior to Qualcomm, Gasser spent five years at Openwave Systems, a mobile browser provider at the time, where she held strategy, product and market research roles. Before Openwave, she worked as a strategy consultant in both London and San Francisco.

Gasser earned a bachelor of arts and masters degrees in economics from Cambridge University, U.K. She also serves as the Board Chair for Athena, a non-profit organization focused on professional advancement for women in STEM fields.
 
“Tandem’s strategic plan focuses on providing the world’s best insulin delivery systems, building relationships and expanding the value we provide our customers, healthcare providers and payors, and using data in new ways to deliver revolutionary insights and experiences,” said Gasser. “There’s meaningful, long-term opportunity for Tandem and I look forward to contributing in my new role.”
 
Tandem Diabetes Care Inc. is a medical device company dedicated to improving the lives of people with diabetes through innovation and customer experience. The company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. The t:slim X2 pump is capable of remote feature updates using a personal computer. Tandem is based in San Diego, Calif.